bit.bio raises €37.4M Series A round
13 June 2020· Cambridge, United Kingdom· health, biotech, ai, b2b, deep_hardware
To grow the talent and operations needed to realize its synthetic biology ambitions and accelerate the drive towards industrial-scale manufacturing of human cells.
Investors
LeadRichard Klausner
Also participating
BlueYard CapitalArch Venture PartnersForesite CapitalBob NelsenJim Tananbaum
About bit.bio
Stage
Series C
Headquarters
Cambridge, United Kingdom
Founded
2016
Team Size
201–500
Sectors
healthbiotechaib2bdeep_hardware